Merck & Co may pay $80 million to settle more Vioxx claims
This article was originally published in Scrip
Executive Summary
Merck & Co has tentatively agreed to pay $80 million to settle 190 outstanding claims involving its withdrawn painkiller Vioxx (rofecoxib) brought by third-party payers, the company disclosed.